Inventor · disambiguated record
Susan Acton
Also filed as: ACTON SUSAN · ACTON SUSAN L · ACTON SUSAN LAURENE
32 granted patents·10 pending applications·388 citations·filing 1994–2022
97Inventor score
Files withMILLENNIUM PHARM INC35MASSACHUSETTS INST TECHNOLOGY3ARTUGEN THERAPEUTICS LTD2MASSACHUSETTE INST OF TECHNOLO1
Top patents by PatentIndex Score
42 records- 0186US6632830B1ACE-2 inhibiting compounds and methods of use thereofMILLENNIUM PHARM INC·Filed 2000·Granted Oct 14, 2003·30 cites·145 claims
- 0285US6884771B1Angiotensin converting enzyme homolog and uses thereforMILLENNIUM PHARM INC·Filed 2000·Granted Apr 26, 2005·8 cites·25 claims
- 0385US6258582B1CSAPTP nucleic acid molecules and uses thereforMILLENNIUM PHARM INC·Filed 1998·Granted Jul 10, 2001·51 cites·23 claims
- 0483US6194556B1Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therforMILLENNIUM PHARM INC·Filed 1997·Granted Feb 27, 2001·54 cites·40 claims
- 0578US7045532B2ACE-2 modulating compounds and methods of use thereofMILLENNIUM PHARM INC·Filed 2001·Granted May 16, 2006·11 cites·40 claims
- 0677US7482171B2Angiotensin converting enzyme homolog and uses thereforMILLENNIUM PHARM INC·Filed 2005·Granted Jan 27, 2009·3 cites·6 claims
- 0775US5925333AMethods for modulation of lipid uptakeMASSACHUSETTS INST TECHNOLOGY·Filed 1995·Granted Jul 20, 1999·48 cites·5 claims
- 0873US6429289B1Class BI and CI scavenger receptorsMASSACHUSETTS INST TECHNOLOGY·Filed 1994·Granted Aug 6, 2002·26 cites·8 claims
- 0968US6610497B1Angiotensin converting enzyme homolog and therapeutic and diagnostic uses thereforMILLENNIUM PHARM INC·Filed 1999·Granted Aug 26, 2003·21 cites·25 claims
- 1064US6030778ADiagnostic assays and kits for body mass disorders associated with a polymorphism in an intron sequence of the SR-BI geneMILLENNIUM PHARM INC·Filed 1997·Granted Feb 29, 2000·31 cites·28 claims
- 1163US5998141AIntronic and polymorphic SR-BI nucleic acids and uses thereforMILLENNIUM PHARM INC·Filed 1997·Granted Dec 7, 1999·21 cites·52 claims
- 1262US6989363B1Angiotensin converting enzyme homolog and therapeutic and diagnostic uses thereforMILLENNIUM PHARM INC·Filed 1998·Granted Jan 24, 2006·14 cites·14 claims
- 1362US2008050840A1Novel protein kinase molecules and uses thereforMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 1461US5965790ASR-BI regulatory sequences and therapeutic methods of useMILLENNIUM PHARM INC·Filed 1997·Granted Oct 12, 1999·16 cites·31 claims
- 1560US2010273989A1Angiotensin converting enzyme homolog and uses thereforMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
- 1657US2003023059A1SR-BI nucleic acids and uses thereforMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
- 1755US7268218B2Cardiovascular system associated protein kinase 3 (CSAPK-3) antibodiesMILLENNIUM PHARM INC·Filed 2004·Granted Sep 11, 2007·0 cites·7 claims
- 1852US6121030ACSAPK-2 protein and uses thereforMILLENNIUM PHARM INC·Filed 1998·Granted Sep 19, 2000·6 cites·6 claims
- 1952US2005255521A159079 and 12599, protein kinase family members and uses thereforMILLENNIUM PHARM INC·Filed 2005·Application pending·0 cites
- 2051US6190874B1Methods for identifying compounds that bind to CSAPK-1MILLENNIUM PHARM INC·Filed 1998·Granted Feb 20, 2001·6 cites·64 claims
- 2151US6008014AMethod of making lipid metabolic pathway compositionsMILLENNIUM PHARM INC·Filed 1996·Granted Dec 28, 1999·6 cites·29 claims
- 2250US6740737B2Cardiovascular system associated protein kinase 2 (CSAPK-2) antibodiesMILLENNIUM PHARM INC·Filed 2001·Granted May 25, 2004·0 cites·11 claims
- 2350US6200770B1Protein kinase molecules and uses thereforMILLENNIUM PHARM INC·Filed 2000·Granted Mar 13, 2001·0 cites·11 claims
- 2450US2025121013A1Use of bacillus amyloliquefaciens for preventing and treating parkinson's diseaseARTUGEN THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 2550US2005037946A1Methods and compositions for treating cardiovascular disease using 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061, 17662, 1468, 12282, 6350, 9035, 1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123, 12788, 17729, 65552, 1261, 21476, 33770, 9380, 2569654, 33556, 53656, 44143, 32612, 10671, 261, 44570, 41922, 2552, 2417, 19319, 43969, 8921, 8993, 955, 32345, 966, 1920, 17318, 1510, 14180, 26005, 554, 16408, 42028, 112091, 13886, 13942, 1673, 54946 or 2419MILLENNIUM PHARM INC·Filed 2004·Application pending·0 cites
- 2650US2024358777A1Compositions comprising bacillus amyloliquefaciens for preventing and treating ulcerative colitisARTUGEN THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 2749US6043040ACsak-3 nucleic acid molecules and uses thereforMILLENNIUM PHARM INC·Filed 1998·Granted Mar 28, 2000·5 cites·108 claims
- 2849US2003129623A1SR-BI regulatory sequences and therapeutic assays based on the sameMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 2947US2003044782A1Diagnostic assays and kits for body mass and cardiovascular disordersFiled 2001·Application pending·0 cites
- 3045US6183962B1Protein kinase molecules and uses thereforMILLENNIUM PHARM INC·Filed 1998·Granted Feb 6, 2001·4 cites·88 claims
- 3145US6146832AProtein kinase molecules and uses thereforMILLENNIUM PHARM INC·Filed 1998·Granted Nov 14, 2000·4 cites·72 claims
- 3244US6180358B1Methods for identifying compounds that bind to CSPAK-2MILLENNIUM PHARM INC·Filed 1998·Granted Jan 30, 2001·4 cites·12 claims
- 3343US6436685B1CSAPTP protein molecules and uses thereforMILLENNIUM PHARM INC·Filed 1998·Granted Aug 20, 2002·3 cites·15 claims
- 3442US6228581B1Human intronic and polymorphic SR-BI nucleic acids and uses thereforMILLENNIUM PHARM INC·Filed 1998·Granted May 8, 2001·6 cites·51 claims
- 3541US6350859B1Class BI and CI scavenger receptorsMASSACHUSETTS INST TECHNOLOGY·Filed 1999·Granted Feb 26, 2002·2 cites·9 claims
- 3639US7078511B1Class BI and CI scavenger receptorsMASSACHUSETTE INST OF TECHNOLO·Filed 1995·Granted Jul 18, 2006·2 cites·16 claims
- 3738US6268135B1Phospholipase molecule and uses thereforMILLENNIUM PHARM INC·Filed 1998·Granted Jul 31, 2001·2 cites·14 claims
- 3838US6146841AMethods for identifying compounds that bind to CSAPK-3 molecules and fragments thereofMILLENNIUM PHARM INC·Filed 1998·Granted Nov 14, 2000·2 cites·64 claims
- 3938US2003215840A1Methods and compositions for treating cardiovascular disease using 1682, 6169, 6193, 7771, 14395, 29002, 33216, 43726, 69292, 26156, 32427, 2402, 7747, 1720, 9151, 60491, 1371, 7077, 33207, 1419, 18036, 16105, 38650, 14245, 58848, 1870, 25856, 32394, 3484, 345, 9252, 9135, 10532, 18610, 8165, 2448, 2445, 64624, 84237, 8912, 2868, 283, 2554, 9464, 17799, 26686, 43848, 32135, 12208, 2914, 51130, 19489, 21833, 2917, 59590, 15992, 2094, 2252, 3474, 9792, 15400, 1452 or 6585 moleculesMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 4037US6130041AHuman intronic and polymorphic SR-BI nucleic acids and uses thereforMILLENNIUM PHARM INC·Filed 1998·Granted Oct 10, 2000·2 cites·42 claims
- 4132US6153417ACSAPK-1 protein and uses thereforMILLENNIUM PHARM INC·Filed 1998·Granted Nov 28, 2000·0 cites·13 claims
- 4230US6214597B1CSAPK-3 protein and uses thereforMILLENNIUM PHARM INC·Filed 1998·Granted Apr 10, 2001·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Susan Acton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →